Valuation: Novoprotein Scientific Inc.

Market Cap 9.07B 1.36B 1.21B 1.12B 1.01B 1.92B 127B 1.97B 13.35B 5.32B 68.2B 5.1B 4.99B 215B P/E 2024
-42.6x
P/E 2025 -36.1x
Enterprise Value 7.42B 1.11B 992M 913M 828M 1.57B 104B 1.61B 10.92B 4.35B 55.76B 4.17B 4.08B 176B EV / Sales 2024
4.57x
EV / Sales 2025 7.78x
Free-Float
30.99%
Yield 2024 *
-
Yield 2025 -
1 day+3.08%
1 week-13.46%
Current month-13.46%
1 month-13.00%
3 months+179.32%
6 months+164.28%
Current year+225.84%
1 week 124
Extreme 124
152.8
1 month 95.12
Extreme 95.12
167.88
Current year 33.2
Extreme 33.2
168.03
1 year 33.2
Extreme 33.2
168.03
3 years 28.56
Extreme 28.56
168.03
5 years 28.56
Extreme 28.56
168.03
10 years 28.56
Extreme 28.56
168.03
Manager TitleAgeSince
Chief Executive Officer 54 2009-09-06
Director of Finance/CFO 53 2013-06-30
Chief Tech/Sci/R&D Officer 36 2015-06-30
Director TitleAgeSince
Chairman 54 2009-09-06
Director/Board Member 54 2019-01-31
Director/Board Member 41 2021-04-14
Change 5-day change 1-year change 3-year change Capi.($)
+3.08%-13.46%+200.41%+140.51% 1.32B
+4.08%-0.25%+45.61%+138.03% 1,206B
+2.07%+4.12%+49.51%+91.08% 665B
+0.90%+1.54%+34.10%+112.46% 515B
+2.77%+0.98%+43.81%+68.46% 381B
+1.19%-0.08%+70.88%+44.79% 362B
+0.29%+1.48%+30.59%+58.32% 307B
+0.98%+1.49%+7.16%+34.78% 289B
+0.89%-0.24%+43.46%+75.84% 249B
+1.48%-0.60%+43.29%+125.79% 207B
Average +1.67%-1.72%+56.88%+89.01% 418.11B
Weighted average by Cap. +2.11%-1.96%+42.88%+95.73%

Financials

2024 2025
Net sales 128M 19.11M 17.06M 15.7M 14.24M 27M 1.79B 27.67M 188M 74.83M 959M 71.72M 70.19M 3.02B 146M 21.94M 19.58M 18.02M 16.35M 30.99M 2.06B 31.76M 216M 85.91M 1.1B 82.34M 80.58M 3.47B
Net income -54.42M -8.15M -7.28M -6.7M -6.08M -11.52M -764M -11.8M -80.1M -31.92M -409M -30.6M -29.94M -1.29B -77.78M -11.65M -10.4M -9.57M -8.69M -16.46M -1.09B -16.87M -114M -45.63M -585M -43.74M -42.8M -1.84B
Net Debt -1.73B -260M -232M -213M -194M -367M -24.36B -376M -2.55B -1.02B -13.04B -976M -955M -41.08B -1.65B -248M -221M -204M -185M -350M -23.23B -359M -2.44B -971M -12.44B -930M -910M -39.17B
Projected Income Statement - Annual - Novoprotein Scientific Inc.
Logo Novoprotein Scientific Inc.
Novoprotein Scientific Inc is a China-based company mainly engaged in the provision of recombinant protein application solutions. The Company’s main businesses include the research and development, production and sales of target and factor proteins, recombinant antibodies, enzymes and reagents, and the provision of full process application solutions in the fields of biopharmaceuticals, in vitro diagnostics, and basic research in life sciences. The Company's main products include novel coronavirus diagnostic antibodies, novel coronavirus diagnostic antigens, novel coronavirus pseudoviruses, novel coronavirus non-structural proteins and messenger ribonucleic acid (mRNA) raw materials enzymes and reagents. Its products and services are mainly used in biological medicine, basic research of life science, in vitro diagnosis, mRNA vaccine drugs and other fields. The Company mainly operates its businesses in the domestic and overseas markets.
Employees
696
Date Price Change Volume
26-11-08 CN¥130.50 +3.08% 6,390,291
26-11-06 CN¥126.60 -13.29% 7,304,334
26-11-05 CN¥146.00 -0.27% 8,930,988
26-11-04 CN¥146.40 +8.44% 8,593,992
26-11-03 CN¥135.00 -12.62% 7,783,570
  1. Stock Market
  2. Stocks
  3. 688137 Stock